T4	Subject 22 27	a man
T5	Treatment 44 70	EGFR-inhibitor (erlotinib)
T6	Treat-Disorder 77 93	cell lung cancer
T7	Effect 108 188	skin manifestations localized in an uncommon area and with an atypical evolution
T8	Gender 24 27	man
T9	Drug 44 58	EGFR-inhibitor
T3	Adverse_event 98 107	developed
E1	Adverse_event:T3